Jiang Zhong Pharmaceutical Co Ltd
SSE:600750

Watchlist Manager
Jiang Zhong Pharmaceutical Co Ltd Logo
Jiang Zhong Pharmaceutical Co Ltd
SSE:600750
Watchlist
Price: 21.78 CNY 0.37% Market Closed
Market Cap: 13.6B CNY
Have any thoughts about
Jiang Zhong Pharmaceutical Co Ltd?
Write Note

Relative Value

The Relative Value of one Jiang Zhong Pharmaceutical Co Ltd stock under the Base Case scenario is 23.73 CNY. Compared to the current market price of 21.78 CNY, Jiang Zhong Pharmaceutical Co Ltd is Undervalued by 8%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
23.73 CNY
Undervaluation 8%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
19
vs Industry
34
Median 3Y
2.9
Median 5Y
2.6
Industry
2.5
Forward
3.1
vs History
25
vs Industry
23
Median 3Y
17.6
Median 5Y
15.1
Industry
21.8
Forward
17
vs History
11
vs Industry
29
Median 3Y
11.1
Median 5Y
9.8
Industry
16.1
vs History
17
vs Industry
23
Median 3Y
15.8
Median 5Y
14.2
Industry
23.8
vs History
15
vs Industry
19
Median 3Y
2.9
Median 5Y
2
Industry
2.1
vs History
12
vs Industry
36
Median 3Y
2.2
Median 5Y
1.8
Industry
2.7
Forward
2.8
vs History
12
vs Industry
41
Median 3Y
3.5
Median 5Y
2.8
Industry
5.2
vs History
20
vs Industry
24
Median 3Y
12.4
Median 5Y
9.2
Industry
13.5
Forward
12.9
vs History
20
vs Industry
29
Median 3Y
12.4
Median 5Y
9.2
Industry
16.8
Forward
15.1
vs History
7
vs Industry
31
Median 3Y
8.6
Median 5Y
6.5
Industry
15.2
vs History
9
vs Industry
23
Median 3Y
12.6
Median 5Y
10
Industry
19.3
vs History
28
vs Industry
28
Median 3Y
2.5
Median 5Y
1.9
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Jiang Zhong Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Jiang Zhong Pharmaceutical Co Ltd
SSE:600750
13.7B CNY 3.2 18.2 13.3 13.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
749.1B USD 18.5 89.9 48.1 53.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
348B USD 4 23.7 11.5 14.9
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
200.1B CHF 3.4 17.4 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP 4.1 31.5 169.4 253.8
CH
Novartis AG
SIX:NOVN
171.5B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
150.1B USD 2.5 35.4 10.5 15.9
P/E Multiple
Earnings Growth P/E to Growth
CN
Jiang Zhong Pharmaceutical Co Ltd
SSE:600750
Average P/E: 30.8
18.2
39%
0.5
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
89.9
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.7
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.4
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Jiang Zhong Pharmaceutical Co Ltd
SSE:600750
Average EV/EBITDA: 414.9
13.3
43%
0.3
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.1
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.5
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.5
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Jiang Zhong Pharmaceutical Co Ltd
SSE:600750
Average EV/EBIT: 1 811.4
13.3
25%
0.5
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.7
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
14.9
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.8
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
15.9
68%
0.2

See Also

Discover More
Back to Top